Transgene SA
Stock Forecast, Prediction & Price Target
Transgene SA Financial Estimates
Transgene SA Revenue Estimates
Transgene SA EBITDA Estimates
Transgene SA Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| €9.99M N/A | €3.12M -68.71% | €1.18M -62.12% | Avg: €99.6M Low: €99.6M High: €99.6M avg. 8312.16% | Avg: €21.6M Low: €21.6M High: €21.6M avg. -78.31% | Avg: €68.1M Low: €68.1M High: €68.1M avg. 215.27% | |
Net Income
% change YoY
| €-20.00M N/A | €-32.81M -64.01% | €-22.32M 31.94% | Avg: €26.15M Low: €26.15M High: €26.15M avg. 217.13% | Avg: €-42.75M Low: €-42.75M High: €-42.75M avg. -263.46% | Avg: €-59.34M Low: €-59.34M High: €-59.34M avg. -38.82% | |
EBITDA
% change YoY
| €-16.54M N/A | €-30.30M -83.16% | €-27.02M 10.83% | Avg: €-99.6M Low: €-99.6M High: €-99.6M avg. -268.56% | Avg: €-21.6M Low: €-21.6M High: €-21.6M avg. 78.31% | Avg: €-68.1M Low: €-68.1M High: €-68.1M avg. -215.27% | |
EPS
% change YoY
| -$0.22 N/A | -$0.33 -50.00% | -$0.22 33.33% | Avg: $0.26 Low: $0.26 High: $0.26 avg. 218.18% | Avg: -$0.43 Low: -$0.43 High: -$0.43 avg. -263.46% | Avg: -$0.59 Low: -$0.59 High: -$0.59 avg. -38.82% | |
Operating Expenses
% change YoY
| €33.73M N/A | €33.25M -1.44% | €31.23M -6.08% | Avg: €168.02M Low: €168.02M High: €168.02M avg. 438.00% | Avg: €36.43M Low: €36.43M High: €36.43M avg. -78.31% | Avg: €114.88M Low: €114.88M High: €114.88M avg. 215.27% | |
FAQ
What is Transgene SA stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -28.38% in 2025-2027.
We have gathered data from N/A analysts. Their low estimate is 26.15M, average is 26.15M and high is 26.15M.
What is Transgene SA stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 2816.37% in 2025-2027.
We have gathered data from N/A analysts. Their low revenue estimate is €99.6M, average is €99.6M and high is €99.6M.
What is Transgene SA stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -28.03% in 2025-2027.
We have gathered data from N/A analysts. Their low earnings per share estimate is $0.26, average is $0.26 and high is €0.26.